Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $10,683 | 725 | 99.6% |
| Education | $46.06 | 8 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,192 | 81 | $0 (2024) |
| Novo Nordisk Inc | $882.25 | 64 | $0 (2024) |
| Lilly USA, LLC | $771.77 | 64 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $741.14 | 42 | $0 (2024) |
| PFIZER INC. | $679.94 | 44 | $0 (2024) |
| GlaxoSmithKline, LLC. | $655.57 | 42 | $0 (2024) |
| Merck Sharp & Dohme LLC | $622.81 | 48 | $0 (2024) |
| Astellas Pharma US Inc | $605.66 | 36 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $445.76 | 33 | $0 (2023) |
| Exact Sciences Corporation | $370.82 | 17 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,949 | 120 | ABBVIE INC. ($254.32) |
| 2023 | $1,689 | 111 | ABBVIE INC. ($415.31) |
| 2022 | $1,469 | 109 | Novo Nordisk Inc ($168.93) |
| 2021 | $1,480 | 97 | AbbVie Inc. ($226.61) |
| 2020 | $958.17 | 67 | Allergan, Inc. ($193.65) |
| 2019 | $741.01 | 52 | GlaxoSmithKline, LLC. ($73.15) |
| 2018 | $1,014 | 71 | AstraZeneca Pharmaceuticals LP ($127.99) |
| 2017 | $1,430 | 106 | AstraZeneca Pharmaceuticals LP ($188.48) |
All Payment Transactions
733 individual payment records from CMS Open Payments — Page 1 of 30
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/26/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.23 | General |
| Category: RESPIRATORY | ||||||
| 12/19/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $17.49 | General |
| Category: Biological | ||||||
| 12/06/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $25.32 | General |
| Category: NEUROSCIENCE | ||||||
| 12/03/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $16.18 | General |
| Category: VACCINES | ||||||
| 11/21/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.87 | General |
| Category: DIABETES | ||||||
| 11/21/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $16.78 | General |
| Category: Cardio-renal | ||||||
| 11/20/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $16.78 | General |
| Category: Oncology | ||||||
| 11/20/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $13.16 | General |
| Category: Gastroenterology | ||||||
| 11/14/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $16.74 | General |
| Category: Diabetes | ||||||
| 11/13/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $14.29 | General |
| Category: PAIN | ||||||
| 11/07/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), VAXNEUVANCE, CAPVAXIVE | Food and Beverage | In-kind items and services | $18.42 | General |
| Category: VACCINE | ||||||
| 11/04/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $5.50 | General |
| Category: NEUROSCIENCE | ||||||
| 10/23/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.83 | General |
| Category: DIABETES | ||||||
| 10/22/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $18.84 | General |
| 10/22/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $16.78 | General |
| Category: Oncology | ||||||
| 10/16/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $17.64 | General |
| Category: PAIN | ||||||
| 10/09/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $8.49 | General |
| Category: NEUROSCIENCE | ||||||
| 10/08/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $19.81 | General |
| Category: Biological | ||||||
| 10/02/2024 | Radius Health, Inc. | Tymlos (Drug) | Food and Beverage | In-kind items and services | $13.09 | General |
| Category: Endocrinology | ||||||
| 09/30/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $21.96 | General |
| Category: VACCINES | ||||||
| 09/26/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.17 | General |
| Category: Gastroenterology | ||||||
| 09/25/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $15.97 | General |
| Category: Diabetes | ||||||
| 09/25/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $5.93 | General |
| Category: Diabetes | ||||||
| 09/24/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $18.15 | General |
| Category: Endocrinology | ||||||
| 09/17/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $15.70 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 30 | 1,672 | 2,632 | $223,083 | $89,561 |
| 2022 | 32 | 1,521 | 2,429 | $214,166 | $87,349 |
| 2021 | 31 | 1,707 | 2,471 | $218,818 | $93,057 |
| 2020 | 32 | 1,695 | 2,436 | $228,059 | $90,402 |
All Medicare Procedures & Services
125 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 154 | 298 | $54,758 | $20,891 | 38.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 126 | 126 | $17,861 | $15,571 | 87.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 120 | 234 | $30,713 | $12,692 | 41.3% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 139 | 139 | $21,163 | $10,619 | 50.2% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 71 | 71 | $8,355 | $5,051 | 60.5% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 17 | 17 | $6,630 | $4,790 | 72.2% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 15 | 15 | $2,599 | $2,376 | 91.4% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 124 | 170 | $12,674 | $2,220 | 17.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 73 | 73 | $3,449 | $2,132 | 61.8% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 13 | 13 | $2,389 | $2,042 | 85.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 138 | 212 | $4,452 | $1,774 | 39.8% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 124 | 171 | $15,441 | $1,762 | 11.4% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 12 | 23 | $4,263 | $1,232 | 28.9% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2023 | 31 | 31 | $11,067 | $1,121 | 10.1% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 37 | 41 | $2,798 | $674.86 | 24.1% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 18 | 24 | $2,696 | $528.66 | 19.6% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 43 | 59 | $2,788 | $527.73 | 18.9% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 16 | 16 | $756.00 | $472.16 | 62.5% |
| 82043 | Urine microalbumin (protein) level | Office | 2023 | 82 | 84 | $3,440 | $471.16 | 13.7% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 28 | 48 | $2,268 | $456.96 | 20.1% |
| 82570 | Creatinine level to test for kidney function or muscle injury | Office | 2023 | 82 | 84 | $2,293 | $422.87 | 18.4% |
| 69210 | Removal of impacted ear wax | Office | 2023 | 11 | 13 | $1,215 | $351.60 | 28.9% |
| 84153 | Psa (prostate specific antigen) measurement, total | Office | 2023 | 15 | 15 | $1,418 | $270.30 | 19.1% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 47 | 331 | $3,129 | $243.49 | 7.8% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 26 | 29 | $1,218 | $220.69 | 18.1% |
About Dr. Kyle Hulme, MD
Dr. Kyle Hulme, MD is a Personal Emergency Response Attendant healthcare provider based in Waco, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/13/2006. The National Provider Identifier (NPI) number assigned to this provider is 1649360421.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Kyle Hulme, MD has received a total of $10,729 in payments from pharmaceutical and medical device companies, with $1,949 received in 2024. These payments were reported across 733 transactions from 54 companies. The most common payment nature is "Food and Beverage" ($10,683).
As a Medicare-enrolled provider, Hulme has provided services to 6,595 Medicare beneficiaries, totaling 9,968 services with total Medicare billing of $360,369. Data is available for 4 years (2020–2023), covering 125 distinct procedure/service records.
Practice Information
- Specialty Personal Emergency Response Attendant
- Other Specialties Family Medicine
- Location Waco, TX
- Active Since 10/13/2006
- Last Updated 01/25/2022
- Taxonomy Code 146D00000X
- Entity Type Individual
- NPI Number 1649360421
Products in Payments
- VRAYLAR (Drug) $702.09
- FARXIGA (Drug) $597.82
- Cologuard Collection Kit (Device) $370.82
- XIFAXAN (Drug) $360.51
- MYRBETRIQ (Drug) $311.93
- UBRELVY (Drug) $288.07
- TRELEGY ELLIPTA (Drug) $275.08
- MOUNJARO (Drug) $266.16
- TRULICITY (Drug) $254.84
- Vascepa (Drug) $235.10
- JARDIANCE (Drug) $221.04
- QULIPTA (Drug) $218.46
- PREVNAR 20 (Biological) $201.84
- Ozempic (Drug) $188.97
- SOLIQUA 100/33 (Biological) $182.54
- Rybelsus (Drug) $177.99
- Victoza (Drug) $167.68
- Veozah (Drug) $161.42
- NURTEC ODT (Drug) $160.76
- INVOKANA (Drug) $146.15
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.